ABRYSVO subst sèche 120 mcg c solv ser pré 10 pce
7680696910031
CH-69691
J07BX
08.08.
1 / 3
google
Details
- Product number
- 6969101
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- A) Lyophilisat: antigenum F prae-fusionatum stabilitum RSV subgrupi A 0.06 mg pro dosi, antigenum F prae-fusionatum stabilitum RSV subgrupi B 0.06 mg pro dosi, trometamolum, trometamoli hydrochloridum, saccharum, mannitolum, polysorbatum 80, natrii chloridum corresp. natrium 0.433 mg, ad pulverem. B) Lösungsmittel: aqua ad iniectabile, pro dosi.
Articles (1)
Abrysvo, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
A
|
0.06 MG | Substance | Wirkstoff (Principe actif) |
|
B
|
- | Substance | HNIDK |
|
A
|
0.06 MG | Substance | Wirkstoff (Principe actif) |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
- | Substance | HNIDK |
|
A
|
0.433 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69691
- Drug name
- Abrysvo, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULIL
- ATC Code
- J07BX
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/08/2024
- Authorization expiration date
- 22/08/2029
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABRYSVO subst sèche 120 mcg c solv ser pré 10 pce
- Description (DE)
- ABRYSVO Trockensub 120 mcg c Solv Fertspr 10 Stk
- Market launch
- 23/08/2024
- Narcotic (BTM)
- No